Teacher Retirement System of Texas purchased a new position in Envista Holdings Co. (NYSE:NVST - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 58,969 shares of the company's stock, valued at approximately $1,138,000.
Several other large investors also recently added to or reduced their stakes in the stock. Venturi Wealth Management LLC boosted its holdings in shares of Envista by 528.4% in the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company's stock worth $38,000 after purchasing an additional 1,638 shares during the period. GAMMA Investing LLC boosted its stake in Envista by 30.5% during the fourth quarter. GAMMA Investing LLC now owns 2,304 shares of the company's stock worth $44,000 after buying an additional 538 shares during the period. Thurston Springer Miller Herd & Titak Inc. bought a new position in Envista during the fourth quarter valued at $53,000. KBC Group NV lifted its holdings in shares of Envista by 63.9% in the 4th quarter. KBC Group NV now owns 7,903 shares of the company's stock worth $152,000 after acquiring an additional 3,082 shares during the last quarter. Finally, Sanctuary Advisors LLC purchased a new position in shares of Envista during the 3rd quarter worth about $228,000.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on NVST shares. New Street Research set a $19.00 price objective on shares of Envista in a research note on Thursday, March 6th. Jefferies Financial Group increased their price target on Envista from $20.00 to $22.00 and gave the stock a "hold" rating in a report on Thursday, January 23rd. Wells Fargo & Company set a $19.00 price objective on Envista in a report on Saturday, March 8th. Piper Sandler increased their target price on Envista from $17.00 to $18.00 and gave the stock a "neutral" rating in a research note on Monday, February 3rd. Finally, UBS Group lowered their target price on shares of Envista from $23.00 to $21.00 and set a "neutral" rating for the company in a research note on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Envista presently has a consensus rating of "Hold" and a consensus price target of $20.18.
View Our Latest Stock Analysis on NVST
Envista Stock Up 2.3 %
Shares of NYSE NVST traded up $0.39 during midday trading on Wednesday, reaching $17.49. 4,197,043 shares of the company's stock traded hands, compared to its average volume of 2,430,248. The company has a market cap of $3.01 billion, a price-to-earnings ratio of -2.69, a P/E/G ratio of 1.27 and a beta of 1.33. The stock's 50 day simple moving average is $19.40 and its 200-day simple moving average is $19.57. The company has a quick ratio of 1.76, a current ratio of 2.04 and a debt-to-equity ratio of 0.44. Envista Holdings Co. has a one year low of $15.15 and a one year high of $23.00.
Envista (NYSE:NVST - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, analysts predict that Envista Holdings Co. will post 1 EPS for the current fiscal year.
About Envista
(
Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
